2015
Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology
FELICIANI, C.; P. JOLY; M.F. JONKMAN; G. ZAMBRUNO; D. ZILLIKENS et al.Základní údaje
Originální název
Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology
Autoři
FELICIANI, C.; P. JOLY; M.F. JONKMAN; G. ZAMBRUNO; D. ZILLIKENS; D. IOANNIDES; C. KOWALEWSKI; Hana JEDLIČKOVÁ; S. KARPATI; B. MARINOVIC; D. MIMOUNI; S. UZUN; S. YAYLI; M. HERTL a L. BORRADORI
Vydání
British Journal of Dermatology, Hoboken, Wiley-Blackwell, 2015, 0007-0963
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30000 3. Medical and Health Sciences
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 4.317
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/15:00083985
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
LINKED-IMMUNOSORBENT-ASSAY; INDIRECT IMMUNOFLUORESCENCE; TOPICAL CORTICOSTEROIDS; MYCOPHENOLATE-MOFETIL; PLASMA-EXCHANGE; DIAGNOSIS; DISEASES; MULTICENTER; AZATHIOPRINE; ACQUISITA
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 24. 9. 2015 16:18, Soňa Böhmová
Anotace
V originále
Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or generalized bullous lesions. In up to 20% of affected patients, bullae may be completely absent, and only excoriations, prurigo-like lesions, eczematous lesions, urticated lesions and/or infiltrated plaques are observed. The disease is significantly associated with neurological disorders. The morbidity of bullous pemphigoid and its impact on quality of life are significant. So far, a limited number of national treatment guidelines have been proposed, but no common European consensus has emerged. Our consensus for the treatment of bullous pemphigoid has been developed under the guidance of the European Dermatology Forum in collaboration with the European Academy of Dermatology and Venereology. It summarizes evidence-based and expert-based recommendations.